The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Open accessAbstract
The effect of significant weight loss on nonalcoholic fatty liver disease remains unclear. In this case series of 36 selected obese patients, we examined the effect of weight loss on nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis (NASH) and hepatic fibrosis. These 36 patients (11 males, 25 females) had paired liver biopsies, the first at the time of laparoscopic adjustable gastric band placement and the second after weight loss. Second biopsies were obtained from two groups: those requiring a subsequent laparoscopic procedure (n = 19) and those with index biopsy score of 2 or greater for zone 3-centric hepatic fibrosis (n = 17). All biopsies were scored, blinded to the patient's identity and clinical condition, for individual histological features and for NASH stage and grade. Initial biopsies demonstrated NASH in 23 patients and steatosis in 12 patients. Repeat biopsies were taken at 25.6 ± 10 months (range, 9-51 months) after band placement. Mean weight loss was 34.0 ± 17 kg, and percentage of excess weight loss was 52 ± 17%. There were major improvements in lobular steatosis, necroinflammatory changes, and fibrosis at the second biopsy ( P < .001 for all). Portal abnormalities remained unchanged. Only four of the repeat biopsies fulfilled the criteria for NASH. There were 18 patients with an initial fibrosis score of 2 or more compared with 3 patients at follow-up ( P < .001). Those with the metabolic syndrome (n = 23) had more extensive changes before surgery and greater improvement with weight loss. In conclusion , weight loss after surgery provides major improvement or resolution of obesity and metabolic syndrome-associated abnormal liver histological features in severely obese subjects. (Hepatology 2004;39:1647-1654.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a seminal biopsy study by Dixon et al., 36 adults underwent paired liver biopsies at ~2 years after AGB: nearly all showed major reductions in lobular steatosis, inflammation, and fibrosis (p < 0.001).”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The proportion meeting NASH criteria fell from 64% pre-operatively to ~11% on follow-up”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“and the number of patients with significant fibrosis (stage ≥ 2) dropped from 18 to three (p < 0.001) [45].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [45]
In the citing paper
“Clinical interventions such as weight loss resulting from dietary changes, bariatric surgery, pharmacological agents, or the use of farnesoid X receptor (FXR) agonists have been associated with fibrosis regression in patients with MASH (256-258).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [257]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Lévy, J., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,023
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
Self-citationLLUSIA, J. B. (1983) · PubMed · Cited by 1,286
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 929
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1053/jhep.2003.50420 · Cited by 744
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D. M., Whitehall, V., Shorthouse, C., Clouston, A. D., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 673
Research works printed but not linked: 1
- Freedman, 2003, Changes in insulin sensitivity and improvements in liver histology in patients with non-alcoholic steatohepatitis (NASH) treated with Pioglitozone., Diabetes, 52, A76
Cited by
Sorted by citations
Items 101–200 of 723
Bariatric surgery for pediatric extreme obesity: now or later?
Inge, T. H., Xanthakos, S. A., & Zeller, M. H. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803525 · Cited by 188
Final results of a long-term, clinical follow-up in fatty liver patients
Dam‐Larsen, S., Becker, U., Franzmann, M., Larsen, K. R., Christoffersen, P., & Bendtsen, F. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520903171284 · Cited by 187
Current status of novel antifibrotic therapies in patients with chronic liver disease
Cohen‐Naftaly, M., & Friedman, S. L. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11413002 · Cited by 187
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
Clark, J. M., Al-Khuraishi, A., Solga, S. F., Alli, P. M., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 187
Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass
Boza, C., Riquelme, A. J., Ibáñez, L., Duarte, I., Norero, E., Paola Viviani, G., Soza, A., Fernandez, J. I., Raddatz, A., Guzmán, S., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002347 · Cited by 183
Böttcher, K., & Pinzani, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.016 · Cited by 190
Cussons, A. J., Watts, G. F., Mori, T. A., & Stuckey, B. G. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0870 · Cited by 183
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats
Muñoz, J., Ros, J., Fernández‐Varo, G., Tugues, S., Morales‐Ruiz, M., Alvarez, C. E., Friedman, S. L., Arroyo, V., & Jiménez, W. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131896 · Cited by 184
Masterton, G., Plevris, J. N., & Hayes, P. C. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04230.x · Cited by 210
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 189
Glass, L. M., Dickson, R. C., Anderson, J. C., Suriawinata, A. A., Putra, J., Berk, B. S., & Toor, A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3380-3 · Cited by 179
Magnetic Resonance Elastography of Liver
Venkatesh, S. K., & Ehman, R. L. (2014) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2014.05.001 · Cited by 178
Anti-fibrogenic strategies and the regression of fibrosis
Kisseleva, T., & Brenner, D. A. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.011 · Cited by 169
Nonalcoholic Fatty Liver Disease as a Complication of Insulin Resistance
Abdelmalek, M. F., & Diehl, A. M. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.001 · Cited by 170
Crossan, C., Tsochatzis, E. A., Longworth, L., Gurusamy, K. S., Davidson, B. R., Rodríguez‐Perálvarez, M., Mantzoukis, K., O’Brien, J., Thalassinos, E., Papastergiou, V., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19090 · Cited by 169
Younossi, Z. M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03710.x · Cited by 167
Barr, J., Vázquez–Chantada, M., Alonso, C., Pérez-Cormenzana, M., Mayo, R., Galán, A., Caballería, J., Martín‐Duce, A., Tran, A., Wagner, C., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1002593 · Cited by 164
Pathophysiology of Liver Fibrosis
Pinzani, M. (2015) · Digestive Diseases · doi:10.1159/000374096 · Cited by 164
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Non-alcoholic fatty liver disease: current concepts and management strategies
Adams, D., Haydon, G. H., & Day, C. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-1-19 · Cited by 159
The Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance
Mathurin, P., Gonzalez, F., Kerdraon, O., Leteurtre, E., Arnalsteen, L., Hollebecque, A., Louvet, A., Dharancy, S., Cocq, P., Jany, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.024 · Cited by 161
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Resolution of nonalcoholic steatohepatits after gastric bypass surgery
Liu, X., Lazenby, A. J., Clements, R. H., Jhala, N., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9086-2 · Cited by 149
Mirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls
Guglielmo, F. F., Venkatesh, S. K., & Mitchell, D. G. (2019) · Radiographics · doi:10.1148/rg.2019190034 · Cited by 148
Hafeez, S., & Ahmed, M. H. (2013) · Journal of Obesity · doi:10.1155/2013/839275 · Cited by 150
Ultrasound in chronic liver disease
Gerstenmaier, J. F., & Gibson, R. N. (2014) · Insights into Imaging · doi:10.1007/s13244-014-0336-2 · Cited by 144
Zelber‐Sagi, S., Godos, J., & Salomone, F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16638830 · Cited by 141
Gan, L., Chitturi, S., & Farrell, G. C. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/831536 · Cited by 135
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
Hamabe, A., Uto, H., Imamura, Y., Kusano, K., Mawatari, S., Kumagai, K., Kure, T., Tamai, T., Moriuchi, A., Sakiyama, T., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0376-z · Cited by 140
Ohki, T., Isogawa, A., Iwamoto, M., Ohsugi, M., Yoshida, H., Toda, N., Tagawa, K., Omata, M., & Koike, K. (2012) · The Scientific World Journal · doi:10.1100/2012/496453 · Cited by 139
Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
Moschen, A. R., Molnar, C., Wolf, A. M., Weiss, H. G., Graziadei, I. W., Kaser, S., Ebenbichler, C. F., Stadlmann, S., Moser, P. L., & Tilg, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.016 · Cited by 136
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
Sasaki, A., Nitta, H., Otsuka, K., Umemura, A., Baba, S., Obuchi, T., & Wakabayashi, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00164 · Cited by 133
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Ciaula, A. D., Passarella, S., Shanmugam, H., Noviello, M., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105375 · Cited by 142
Non-alcoholic steatohepatitis and metabolic syndrome
Machado, M. V., & Cortez‐Pinto, H. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241677.40170.17 · Cited by 133
Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
Hernández‐Rodas, M. C., Valenzuela, R., & Videla, L. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025168 · Cited by 131
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
Guha, I. N., Parkes, J., Roderick, P., Harris, S., & Rosenberg, W. M. (2006) · Gut · doi:10.1136/gut.2006.091454 · Cited by 128
Update on non-alcoholic fatty liver disease in children
Papandreou, D., Rousso, I., & Mavromichalis, I. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.02.002 · Cited by 126
The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver
Wilkinson, A. L., Qurashi, M., & Shetty, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00990 · Cited by 121
Subichin, M., Clanton, J., Makuszewski, M., Bohon, A., Zografakis, J. G., & Dan, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.015 · Cited by 124
Nonalcoholic fatty liver disease in the pediatric population: a review
Wieckowska, A., & Feldstein, A. E. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000172816.79637.c5 · Cited by 124
Changes in Liver Histology Accompanying Massive Weight Loss after Gastroplasty for Morbid Obesity
Stratopoulos, C., Papakonstantinou, A., Terzis, I., Spiliadi, C., Dimitriades, G., Komesidou, V., Kitsanta, P., Argyrakos, T., & Hadjiyannakis, E. J. (2005) · Obesity Surgery · doi:10.1381/0960892055002239 · Cited by 123
Bariatric surgery in patients with liver cirrhosis
Shimizu, H., Phuong, V., Maia, M., Kroh, M., Chand, B., Schauer, P. R., & Brethauer, S. A. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.07.021 · Cited by 122
Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis.
Yilmaz, Y. N., Yönal, O., Deyneli, O., Çelikel, Ç., Kalaycı, C., & Duman, D. (2012) · PubMed · Cited by 122
Diabetes in chronic liver disease: from old concepts to new evidence
Picardi, A., D’Avola, D., Gentilucci, U. V., Galati, G., Fiori, E., Spataro, S., & Afeltra, A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.636 · Cited by 123
High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption
Sonnweber, T., Ress, C., Nairz, M., Theurl, I., Schroll, A., Murphy, A. T., Wroblewski, V., Witcher, D. R., Moser, P., Ebenbichler, C. F., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.10.013 · Cited by 117
Treatment of non-alcoholic fatty liver disease.
(2007) · PubMed Central · Cited by 118
Lefebvre, P., Lalloyer, F., Baugé, E., Pawlak, M., Gheeraert, C., Dehondt, H., Vanhoutte, J., Woitrain, E., Hennuyer, N., Mazuy, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92264 · Cited by 117
Review article: diagnosis and treatment of non‐alcoholic fatty liver disease
OH, M. K., Winn, J., & Poordad, F. F. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03752.x · Cited by 120
Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116
Surgical Treatment of Morbid Obesity
Crookes, P. F. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144928 · Cited by 116
Functional Immune Anatomy of the Liver—As an Allograft
Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 117
Angelico, F., Burattin, M., Alessandri, C., Ben, M. D., & Lirussi, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005166.pub2 · Cited by 118
RetractedHe, K., Li, Y., Guo, X., Zhong, L., & Tang, S. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000914 · Cited by 113
Taitano, A. A., Markow, M., Finan, J. E., Wheeler, D. E., Gonzalvo, J. P., & Murr, M. M. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-014-2678-y · Cited by 112
Garg, H., Aggarwal, S., Shalimar, S., Yadav, R., Gupta, S. D., Agarwal, L., & Agarwal, S. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.09.005 · Cited by 112
Shiffman, M. L., Freilich, B. L., Vuppalanchi, R., Watt, K. D. S., Chan, J. L., Spada, A., Hagerty, D. T., & Schiff, E. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15030 · Cited by 115
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Ali, R., & Cusi, K. J. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 111
Histologic Spectrum of Nonalcoholic Fatty Liver Disease in Morbidly Obese Adolescents
Xanthakos, S. A., Miles, L., Bucuvalas, J. C., Daniels, S. R., García, V., & Inge, T. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00978-x · Cited by 110
Review: Treatment options for nonalcoholic fatty liver disease
Lam, B. P., & Younossi, Z. M. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09359964 · Cited by 108
Heye, T. J., Yang, S.-R., Bock, M., Brost, S., Weigand, K., Longerich, T., Kauczor, H., & Hosch, W. P. (2012) · European Radiology · doi:10.1007/s00330-012-2378-5 · Cited by 107
Jin, Y., Kim, K. M., Hwang, S., Lee, S. G., Ha, T., Song, G., Jung, D., Kim, K., Yu, E., Shim, J. H., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07165.x · Cited by 106
Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts
Liu, X., Xu, J., Brenner, D. A., & Kisseleva, T. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0018-7 · Cited by 108
Thomas, E. L. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5813 · Cited by 102
Jang, H. R., Park, H., Kang, D., Chung, H., Nam, M. H., Lee, Y., Park, J., & Lee, H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0293-4 · Cited by 105
Cellular basis of hepatic fibrosis and its role in inflammation and cancer
Kocabayoglu, P. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s368 · Cited by 101
Hepatic Fibrosis: Evaluation with Semiquantitative Contrast-enhanced CT
Varenika, V., Fu, Y., Maher, J. J., Gao, D., Kakar, S., Cabarrus, M. C., & Yeh, B. M. (2012) · Radiology · doi:10.1148/radiol.12112452 · Cited by 100
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Lirussi, F., Azzalini, L., Orando, S., Orlando, R., & Angelico, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004996.pub3 · Cited by 100
Nonalcoholic steatohepatitis: pathologic features and differential diagnosis
Brunt, E. M. (2005) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.04.002 · Cited by 100
Ismail, M. H., & Pinzani, M. (2009) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.45072 · Cited by 100
Burton, P. R., Brown, W. A., Laurie, C., Richards, M., Afkari, S., Yap, K. S. K., Korin, A., Hebbard, G. S., & O’Brien, P. E. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9845-3 · Cited by 98
Self-citationFarhangi, M. A., Javid, A. Z., & Dehghan, P. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2015.10.009 · Cited by 96
Food components with antifibrotic activity and implications in prevention of liver disease
Bae, M., Park, Y., & Lee, J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.003 · Cited by 94
In vitro reversion of activated primary human hepatic stellate cells
Taghdouini, A. E., Najimi, M., Sancho‐Bru, P., Sokal, E. M., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 92
Tai, C.-M., Huang, C.-K., Hwang, J.-C., Chiang, H., Chang, C.-Y., Lee, C.-T., Yu, M.-L., & Lin, J.-T. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0579-7 · Cited by 91
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis
Portincasa, P., Grattagliano, I., Lauterburg, B. H., Palmieri, V. O., Palasciano, G., & Stellaard, F. (2006) · Clinical Science · doi:10.1042/cs20050346 · Cited by 91
Health Benefits of Long-Term Weight-Loss Maintenance
Rueda‐Clausen, C. F., Ogunleye, A. A., & Sharma, A. M. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034434 · Cited by 93
Determination of Normal Hepatic Elasticity by Using Real-time Shear-wave Elastography
Suh, C. H., Kim, S. Y., Kim, K. W., Lim, Y., Lee, S., Lee, M.-G., Lee, J.-B., Lee, S., & Yu, E. (2014) · Radiology · doi:10.1148/radiol.14131251 · Cited by 90
Tapper, E. B., Sengupta, N., Hunink, M. G. M., Afdhal, N. H., & Lai, M. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.241 · Cited by 90
Akhtar, E., Manne, V., & Saab, S. (2014) · Liver International · doi:10.1111/liv.12576 · Cited by 90
Wang, Y., Zhou, M., Lam, K. S. L., & Xu, A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200012 · Cited by 90
Koda, M., Kawakami, M., Murawaki, Y., & Senda, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2107-z · Cited by 87
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
Portincasa, P., Grattagliano, I., Palmieri, V. O., & Palasciano, G. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.10.014 · Cited by 86
The metabolic syndrome and nonalcoholic fatty liver disease in children
Sundaram, S. S., Zeitler, P. S., & Nadeau, K. J. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832cb16f · Cited by 85
Advances in antifibrotic therapy
Ghiassi–Nejad, Z., & Friedman, S. L. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.803 · Cited by 84
Vonlaufen, A., Phillips, P. A., Xu, Z., Zhang, X., Yang, L., Pirola, R. C., Wilson, J. S., & Apte, M. V. (2010) · Gut · doi:10.1136/gut.2010.211250 · Cited by 83
Should Nonalcoholic Fatty Liver Disease Be Renamed?
Loria, P., Lonardo, A., & Carulli, N. (2005) · Digestive Diseases · doi:10.1159/000084728 · Cited by 83
Therapy of nonalcoholic fatty liver disease: current status.
Duvnjak, M., Tomašić, V., Gomerčić, M., Duvnjak, L. S., Baršić, N., & Lerotić, I. (2009) · PubMed · Cited by 82
Athyros, V. G., Γιουλεμέ, Ό., Ganotakis, E. S., Elisaf, M., Τζιόμαλος, Κ., Vassiliadis, T. G., Liberopoulos, E. N., Theocharidou, E., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25554 · Cited by 82
Perspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 87
Obesity, weight loss and bariatric surgery
O’Brien, P. E., Brown, W. A., & Dixon, J. B. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb07061.x · Cited by 81
Self-citationJanevski, M., Ratnayake, S., Siljanovski, S., McGlynn, M. A., Cameron-Smith, D., & Lewandowski, P. (2012) · Food Funct. · doi:10.1039/c1fo10111k · Cited by 76
Raj, P., Gomes, R. M., Kumar, S. S., Senthilnathan, P., Karthikeyan, P., Annapoorni, S., & Palanivelu, C. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.006 · Cited by 80
Kim, Y., Chang, Y., Cho, Y. K., Ahn, J., Shin, H. C., & Ryu, S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.006 · Cited by 80
Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis
Zhou, H., Luo, P., Li, P., wang, G., Yi, X., Fu, Z., Sun, X., Cui, B., Zhu, L., & Zhu, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06011-1 · Cited by 79
Ohki, T., Isogawa, A., Toda, N., & Tagawa, K. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0383-1 · Cited by 80
Kahal, H., Abouda, G. F., Rigby, A. S., Coady, A., Kilpatrick, E. S., & Atkin, S. L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12369 · Cited by 79
How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
Ghaemi, A., Taleban, F. A., Hekmatdoost, A., Rafiei, A., Hosseini, V., Amiri, Z., Homayounfar, R., & Fakheri, H. T. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.15227 · Cited by 80
Morbid Obesity and Nutrition Support: Is Bigger Different?
Choban, P. S., & Dickerson, R. N. (2005) · Nutrition in Clinical Practice · doi:10.1177/0115426505020004480 · Cited by 77
Federico, A., Dallio, M., Tolone, S., Gravina, A. G., Patrone, V., Romano, M., Tuccillo, C., Mozzillo, A. L., Amoroso, V., Misso, G., et al. (2016) · PubMed · Cited by 77
Metadata
- Authors
- Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Dixon, John B.
- ORCID
- Dixon, John B.
- Venue
- Hepatology
- Published
- 2004-06
- Volume
- 39
- Issue
- 6
- Pages
- 1647-1654
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2063671857
- Cited by
- 727
- References
- 35
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 19 · 2021: 27 · 2020: 20 · 2019: 31 · 2018: 26 · 2017: 36 · 2016: 32 · 2015: 44 · 2014: 33 · 2013: 38 · 2012: 38
- FWCI
- 40.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, liver fibrosis, weight loss, laparoscopic adjustable gastric band, bariatric surgery, obesity, metabolic syndrome, liver histopathology, steatosis, necroinflammation
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Male, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
